TWD 92.3
(-9.95%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 2.9 Billion TWD | 4.37% |
2022 | 2.77 Billion TWD | -3.99% |
2021 | 2.89 Billion TWD | 62.46% |
2020 | 1.78 Billion TWD | -4.25% |
2019 | 1.86 Billion TWD | 1.99% |
2018 | 1.82 Billion TWD | 17.28% |
2017 | 1.55 Billion TWD | 20.85% |
2016 | 1.28 Billion TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 2.78 Billion TWD | -1.95% |
2024 Q1 | 2.84 Billion TWD | -2.08% |
2023 FY | 2.9 Billion TWD | 4.37% |
2023 Q4 | 2.9 Billion TWD | -2.24% |
2023 Q3 | 2.96 Billion TWD | 2.2% |
2023 Q2 | 2.9 Billion TWD | 2.88% |
2023 Q1 | 2.82 Billion TWD | 1.54% |
2022 Q2 | 2.58 Billion TWD | -1.18% |
2022 Q1 | 2.61 Billion TWD | -3.48% |
2022 Q3 | 3 Billion TWD | 16.58% |
2022 Q4 | 2.77 Billion TWD | -7.65% |
2021 Q4 | 2.7 Billion TWD | 37.03% |
2021 Q3 | 1.97 Billion TWD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -2165.489% |
Level Biotechnology Inc. | 822.67 Million TWD | -252.618% |
Sagittarius Life Science Corp | 664.72 Million TWD | -336.406% |
NeoCore Technology Co., Ltd. | 548.74 Million TWD | -428.638% |
TaiMed Biologics Inc. | 3.89 Billion TWD | 25.502% |
GlycoNex Incorporation | 1.55 Billion TWD | -86.815% |
VBI | 452.1 Million TWD | -541.645% |
GeneReach Biotechnology Corp. | 1.17 Billion TWD | -146.645% |
Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -287.524% |
SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -666.697% |
Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | -155.846% |
Visgeneer Inc. | 397.17 Million TWD | -630.379% |
Mycenax Biotech Inc. | 3.77 Billion TWD | 23.061% |
Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | -34.361% |
G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | -228.491% |
Neith Corporation | 192.15 Million TWD | -1409.678% |
Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 52.387% |
TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -3843.678% |
Enimmune corporation | 604.82 Million TWD | -379.623% |
TaiRx, Inc. | 833.74 Million TWD | -247.935% |
CHO Pharma, Inc. | 3.08 Billion TWD | 5.999% |
EirGenix Inc. | 11.16 Billion TWD | 74.012% |
BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -406.141% |
Sunny Pharmtech Inc. | 1.71 Billion TWD | -69.409% |
Lin BioScience, Inc. | 3.59 Billion TWD | 19.346% |
BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | -176.149% |
Feng Chi Biotech Corp. | 301.03 Million TWD | -863.649% |
Bio Preventive Medicine Corp. | 264.65 Million TWD | -996.095% |
Lukas Biomedical Inc. | 441.19 Million TWD | -557.514% |
RBC Bioscience Corporation | 753.79 Million TWD | -284.841% |
BiOptic Inc. | 613.77 Million TWD | -372.633% |
BRIM Biotechnology, Inc. | 1.77 Billion TWD | -63.093% |
Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | -150.138% |
Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -349.856% |
Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 6.611% |
Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -1860.936% |
NaviFUS Corp. | 490.53 Million TWD | -491.373% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | -136.669% |
Sinew Pharma Inc. | 1.36 Billion TWD | -112.773% |
Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -448.221% |
Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | -149.778% |
Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | -75.145% |
AP Biosciences Inc | 890.75 Million TWD | -225.666% |
Medigen Biotechnology Corp. | 8.52 Billion TWD | 65.981% |
3D Global Biotech Inc. | 324.14 Million TWD | -794.928% |
Pharmosa Biopharm Inc. | 1.33 Billion TWD | -117.516% |
Intech Biopharm Corporation | 2.71 Billion TWD | -7.002% |
Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 81.119% |
Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -607.089% |
TWi Biotechnology, Inc. | 396.85 Million TWD | -630.977% |
Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | -39.74% |
TCI GENE Inc. | 1.16 Billion TWD | -148.803% |
MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -884.752% |
Senhwa Biosciences, Inc. | 1.36 Billion TWD | -112.78% |
Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | -208.028% |
NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -315.332% |
PharmaEngine, Inc. | 3.95 Billion TWD | 26.633% |
Savior Lifetec Corporation | 3.82 Billion TWD | 24.114% |
TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | -135.876% |
OBI Pharma, Inc. | 5.6 Billion TWD | 48.234% |
Meribank Biotech Co., Ltd | 1.06 Billion TWD | -173.152% |
Acepodia, Inc. | 6.81 Billion TWD | 57.456% |
Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 24.19% |